Advances in Large-Scale Extracellular Vesicle Separation

This application note discusses advances in large-scale extracellular vesicle (EV) separation, focusing on the challenges and solutions in the context of therapeutic applications. It outlines the limitations of traditional separation methods such as ultracentrifugation and precipitation, which are often unsuitable for large-scale operations due to issues like low productivity and potential damage to EVs. The document introduces size exclusion chromatography (SEC) as a preferred method for EV isolation, highlighting its advantages in terms of simplicity, speed, and high recovery rates. The qEV PurePath for Therapeutics service is presented as a customizable workflow designed to optimize EV isolation from large volumes, catering to the needs of therapeutics and diagnostics sectors. Key steps in the EV isolation process, including clarification and the use of SEC, are detailed, emphasizing the importance of selecting appropriate methods to achieve high purity and recovery of EVs. The note concludes by underscoring the growing significance of EVs in clinical applications and the need for efficient separation techniques.